Enhabit (NYSE:EHAB) Releases Quarterly Earnings Results, Meets Expectations

Enhabit (NYSE:EHAB) released its quarterly earnings data on Wednesday. The company reported $0.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.14, FiscalAI reports. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The firm had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million.

Enhabit Stock Performance

NYSE:EHAB traded down $0.01 during mid-day trading on Thursday, hitting $13.60. 272,745 shares of the company’s stock traded hands, compared to its average volume of 1,275,489. The firm has a market capitalization of $688.30 million, a price-to-earnings ratio of -54.40 and a beta of 1.56. The firm has a 50 day moving average of $10.96 and a two-hundred day moving average of $9.30. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.75. Enhabit has a 12 month low of $6.47 and a 12 month high of $13.64.

Analyst Ratings Changes

A number of research firms have recently weighed in on EHAB. Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and raised their price target for the stock from $12.50 to $13.80 in a research note on Monday, February 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Wolfe Research set a $12.00 target price on shares of Enhabit in a research report on Thursday, January 8th. Citigroup restated a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and an average target price of $13.31.

Institutional Investors Weigh In On Enhabit

Hedge funds have recently modified their holdings of the business. AQR Capital Management LLC increased its position in Enhabit by 115.6% during the first quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock worth $1,867,000 after acquiring an additional 115,456 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Enhabit by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock worth $262,000 after purchasing an additional 1,248 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Enhabit by 110,987.5% during the 1st quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after purchasing an additional 8,879 shares during the period. Empowered Funds LLC increased its holdings in shares of Enhabit by 8.4% during the 1st quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after purchasing an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC acquired a new position in shares of Enhabit during the first quarter valued at about $114,000.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.